An Open-Label Study to Assess the Effects of Repeated Twice-Daily Doses of Ketoconazole on the Steady-State Pharmacokinetics of JNJ-38518168 in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 18 Mar 2013
At a glance
- Drugs Ketoconazole (Primary) ; Toreforant (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacokinetics
- 11 Oct 2012 Planned initiation date changed from 1 Sep 2012 to 1 Oct 2012 as reported by ClinicalTrials.gov.
- 01 Oct 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 25 Sep 2012 New trial record